Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
1(14%)
Results Posted
0%(0 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_1
1
14%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
60.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (16.7%)
N/A5 (83.3%)

Trials by Status

completed343%
enrolling_by_invitation114%
recruiting114%
terminated229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7